Flow cytometry’s next chapter is here. Opening the door to deeper immunological insights, Cytek Biosciences Inc., a leading provider of flow cytometry instrumentation, today announced that it has ...
A recent study described the use of multiparameter flow cytometry to detect minimal residual disease, with an 8-color flow cytometric method with a 105 sensitivity, using monoclonal antibodies in ...
Flow cytometry is a widely used analytical technique that distinguishes between cell populations depending on the presence or absence of chosen markers. However, the number of markers that can be ...
Flow cytometry panel building can be daunting, whether you’re working with a 4-color panel or a complex 30-color setup. This article explores common challenges faced by flow cytometry users, such as ...
The Flow Cytometry shared resource stays at the leading edge of technology. Close ties to industry allow us to offer users early access to new reagents and instrumentation. We help users realize a ...
These examples illustrate our increasing awareness of the complexity of the immune system. As many diseases are associated with expansions or reductions in major leukocyte subsets (for example, ...
High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Fluorescent dye performance heavily impacts both the quality and ...
More than 100 functionally distinct populations of lymphocytes can be identified in the peripheral blood of humans; each of these cell types undoubtedly has a unique role in the organization and ...
Flow cytometry’s next chapter is here. Opening the door to deeper immunological insights, Cytek Biosciences Inc., a leading provider of flow cytometry instrumentation, today announced that it has ...
[Fremont, CA, USA] – Flow cytometry’s next chapter is here. Opening the door to deeper immunological insights, Cytek Biosciences Inc., a leading provider of flow cytometry instrumentation, announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results